Intelligent Bio Solutions Inc. - Common Stock INBS 深 滬
等待開盤 12-12 09:30:00 美东时间
0.7246
+0.001
+0.12%
華盛通- 最 高0.732
- 今 開0.72
- 成交量 7.92万股
- 最 低 0.7038
- 昨 收 0.7237
- 總市值 632.89万
- 52周最高 2.75
- 市盈率 靜 --
- 換手率 0.91%
- 52周最低 0.637
- 委 比 80.50%
- 總股本 873.44万
- 歷史最高 3417.60
- 量 比 0.99
- 振 幅 3.90%
- 歷史最低 0.637
- 每 手 1
- 風險率 0.43%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Intelligent Bio Solutions Q1 EPS $(0.35) Up From $(0.70) YoY, Sales $1.112M Up From $872.287K YoY
Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(0.35) per share. This is a 50 percent increase over losses of $(0.70) per share from the same period last year. The company reported $1.112 million
11-12 21:37
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480
Intelligent Bio Solutions Inc. reported a 50% increase in new customer accounts during its fiscal first quarter of 2025, reaching over 480 active accounts. Key growth sectors include maritime, transportation, logistics, electrical and electronic manufacturing, construction, and government administration, with the latter being a new entry. The UK market showed strong expansion, with 91% of new accounts being first-time adopters. The company's fing...
10-30 12:30
Intelligent Bio Solutions shares are trading higher after the company announced a UK contract with an industrial service provider.
Intelligent Bio Solutions shares are trading higher after the company announced...
10-23 20:33
Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider
Intelligent Bio Solutions Inc. (INBS) has secured a major contract with one of the UK's largest industrial service providers, marking a significant UK deployment of its rapid, non-invasive drug testing technology. The customer, a global leader in energy, defense, and industrial sectors, employs over 30,000 staff worldwide and 3,000 within the UK and Ireland. Transitioning from traditional urine-based testing, the company expects faster, cleaner, ...
10-23 12:30
Intelligent Bio Solutions Approves Incentive Plan Amendment
Intelligent Bio Solutions ( ($INBS) ) has shared an update. On October 16, 2025...
10-22 05:04
Intelligent Bio Solutions Initiates Clinical Studies For Fingerprint Drug Screening System; Targets FDA 510(k) Clearance In H2 2026 For Codeine Detection
The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening SystemINBS anticipates FDA 510(k) clearance in the second half of 2026
09-26 20:37
Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance
<p>Intelligent Bio Solutions Inc. (INBS) plans to initiate clinical studies for its Intelligent Fingerprinting Drug Screening System by the end of 2025, aiming to obtain FDA 510(k) clearance by the second half of 2026. The company has outlined a timeline to strengthen its submission with additional data. Currently, the technology is used by over 450 accounts in 24 countries and continues to expand globally.</p>
09-26 12:30
Intelligent Bio Solutions Extends Warrant Termination Date
The latest announcement is out from Intelligent Bio Solutions ( ($INBS) ). On S...
09-26 05:30
Intelligent Bio Solutions Receives FDA Feedback, Preparing To Resubmit 510(k) For Intelligent Fingerprinting Drug Screening System
Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today provided an update on its FDA 510(k) clearance
09-17 20:34
